BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22028287)

  • 1. Measuring in vivo tumor pHe with CEST-FISP MRI.
    Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD
    Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved pH measurements with a single PARACEST MRI contrast agent.
    Sheth VR; Liu G; Li Y; Pagel MD
    Contrast Media Mol Imaging; 2012; 7(1):26-34. PubMed ID: 22344877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.
    Liu G; Li Y; Sheth VR; Pagel MD
    Mol Imaging; 2012 Feb; 11(1):47-57. PubMed ID: 22418027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide.
    Liu G; Li Y; Pagel MD
    Magn Reson Med; 2007 Dec; 58(6):1249-56. PubMed ID: 18046705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI.
    Chen LQ; Howison CM; Jeffery JJ; Robey IF; Kuo PH; Pagel MD
    Magn Reson Med; 2014 Nov; 72(5):1408-17. PubMed ID: 24281951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multislice CEST MRI improves the spatial assessment of tumor pH.
    Randtke EA; Granados JC; Howison CM; Pagel MD; Cárdenas-Rodríguez J
    Magn Reson Med; 2017 Jul; 78(1):97-106. PubMed ID: 27465207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies.
    Ali MM; Liu G; Shah T; Flask CA; Pagel MD
    Acc Chem Res; 2009 Jul; 42(7):915-24. PubMed ID: 19514717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH imaging of mouse kidneys in vivo using a frequency-dependent paraCEST agent.
    Wu Y; Zhang S; Soesbe TC; Yu J; Vinogradov E; Lenkinski RE; Sherry AD
    Magn Reson Med; 2016 Jun; 75(6):2432-41. PubMed ID: 26173637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Frequency-Selective pH-Responsive paraCEST Agent.
    Ratnakar SJ; Chirayil S; Funk AM; Zhang S; Queiró JF; Geraldes CFGC; Kovacs Z; Sherry AD
    Angew Chem Int Ed Engl; 2020 Nov; 59(48):21671-21676. PubMed ID: 32726500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
    Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
    Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWIFT-CEST: a new MRI method to overcome T₂ shortening caused by PARACEST contrast agents.
    Soesbe TC; Togao O; Takahashi M; Sherry AD
    Magn Reson Med; 2012 Sep; 68(3):816-21. PubMed ID: 22213371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI.
    Ali MM; Yoo B; Pagel MD
    Mol Pharm; 2009; 6(5):1409-16. PubMed ID: 19298054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEST-MRI for glioma pH quantification in mouse model: Validation by immunohistochemistry.
    Ferrauto G; Di Gregorio E; Auboiroux V; Petit M; Berger F; Aime S; Lahrech H
    NMR Biomed; 2018 Nov; 31(11):e4005. PubMed ID: 30256478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ytterbium-based PARACEST agent: feasibility of CEST imaging on a clinical MR scanner.
    Takayama Y; Yoshiura T; Nishie A; Nakayama T; Hatakenaka M; Kato N; Yoshise S; Keupp J; Burdinski D; Honda H
    Magn Reson Med Sci; 2012; 11(1):35-41. PubMed ID: 22450385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-responsive paramagnetic CEST agents.
    Angelovski G; Chauvin T; Pohmann R; Logothetis NK; Tóth E
    Bioorg Med Chem; 2011 Feb; 19(3):1097-105. PubMed ID: 20691598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous experimental determination of labile proton fraction ratio and exchange rate with irradiation radio frequency power-dependent quantitative CEST MRI analysis.
    Sun PZ; Wang Y; Xiao G; Wu R
    Contrast Media Mol Imaging; 2013; 8(3):246-51. PubMed ID: 23606428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NiCEST approach: nickel(II) paraCEST MRI contrast agents.
    Olatunde AO; Dorazio SJ; Spernyak JA; Morrow JR
    J Am Chem Soc; 2012 Nov; 134(45):18503-5. PubMed ID: 23102112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic PARACEST contrast agents for magnetic resonance imaging.
    Pikkemaat JA; Wegh RT; Lamerichs R; van de Molengraaf RA; Langereis S; Burdinski D; Raymond AY; Janssen HM; de Waal BF; Willard NP; Meijer EW; Grüll H
    Contrast Media Mol Imaging; 2007; 2(5):229-39. PubMed ID: 17937448
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.